Quarterly ResultAug 5, 2026, 04:19 PM
Biomea Fusion Q2 Net Loss Narrows to $8.3M; Going Concern Doubt Raised
AI Summary
Biomea Fusion, Inc. reported a reduced net loss for the second quarter of 2026, with net loss decreasing to $8.3 million from $20.7 million in the prior year. Despite this improvement, the company's accumulated deficit reached $469.8 million, and its cash, cash equivalents, and restricted cash stood at $35.2 million as of June 30, 2026. Management expressed substantial doubt about the company's ability to continue as a going concern, indicating that current financial resources are insufficient to fund operations for the next twelve months and additional capital will be required.
Key Highlights
- Q2 2026 net loss decreased to $(8.3) million from $(20.7) million in Q2 2025.
- Q2 2026 net loss per share improved to $(0.12) from $(0.51) in Q2 2025.
- Cash, cash equivalents, and restricted cash totaled $35.2 million as of June 30, 2026.
- Accumulated deficit reached $469.8 million as of June 30, 2026.
- Management raised substantial doubt about the company's ability to continue as a going concern.
- Total operating expenses for Q2 2026 decreased to $12.8 million from $21.3 million in Q2 2025.
- Net cash used in operating activities for H1 2026 was $(21.7) million, down from $(44.9) million in H1 2025.
- Warrant liability decreased to $14.3 million from $17.8 million, with a $3.5 million gain.
Price Impact
More from BMEA